Literature DB >> 8631025

Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer.

M A Watson1, T P Fleming.   

Abstract

In this report, we describe a novel cDNA isolated from a primary human breast adenocarcinoma and differentially expressed in several breast carcinoma cell lines. The protein encoded by this cDNA, which we have named mammaglobin, is homologous to a family of secreted proteins that includes rat prostatic steroid-binding protein subunit C3, human Clara cell 10-kilodalton protein, and rabbit uteroglobin. Expression of the mammaglobin gene is restricted to the adult mammary gland. More significantly, in an analysis of 35 breast tumor biopsies, mammaglobin mRNA levels were increased at least 10-fold relative to normal breast tissue in 23% of cases. The breast-specific expression of this potentially secreted protein and its frequent overexpression in primary human breast tumors suggest that mammaglobin may be a novel marker for the management of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631025

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  63 in total

1.  Molecular detection of breast cancer markers.

Authors:  K M Verbanac
Journal:  Mol Diagn       Date:  2001-06

2.  Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen.

Authors:  Venkataswarup Tiriveedhi; Nayan J Sarma; Vijay Subramanian; Timothy P Fleming; William E Gillanders; Thallachallour Mohanakumar
Journal:  Hum Immunol       Date:  2011-10-23       Impact factor: 2.850

3.  Further evidence to support the melanocytic origin of MDA-MB-435.

Authors:  G Ellison; T Klinowska; R F R Westwood; E Docter; T French; J C Fox
Journal:  Mol Pathol       Date:  2002-10

Review 4.  The detection of circulating breast cancer cells in blood.

Authors:  A M Gilbey; D Burnett; R E Coleman; I Holen
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

5.  Detection of circulating tumor cells in peripheral blood of breast cancer patients during or after therapy using a multigene real-time RT-PCR assay.

Authors:  Barbara K Zehentner; Heather Secrist; Dawn C Hayes; Xinqun Zhang; Richard C Ostenson; Steven Loop; Gary Goodman; Raymond L Houghton; David H Persing
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

6.  Expression of two breast-specific molecules in the lung.

Authors:  Florent Hube; Yvonne Myal; Etienne Leygue; Jerome Rollin; Yves Gruel
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

7.  Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study.

Authors:  V Luyckx; J F Durant; A Camboni; S Gilliaux; C A Amorim; A Van Langendonckt; L M Irenge; J L Gala; J Donnez; M M Dolmans
Journal:  J Assist Reprod Genet       Date:  2013-08-29       Impact factor: 3.412

8.  Trial watch: Naked and vectored DNA-based anticancer vaccines.

Authors:  Norma Bloy; Aitziber Buqué; Fernando Aranda; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

9.  Relationship between mammaglobin expression and estrogen receptor status in breast tumors.

Authors:  Xiao-feng Guan; Mohammad K Hamedani; Adewale Adeyinka; Christina Walker; Angela Kemp; Leigh C Murphy; Peter H Watson; Etienne Leygue
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

Review 10.  Applications of major histocompatibility complex class I molecules expressed as single chains.

Authors:  Tina Primeau; Nancy B Myers; Y Y Lawrence Yu; Lonnie Lybarger; Xiaoli Wang; Steven M Truscott; Ted H Hansen; Janet M Connolly
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.